Literature DB >> 27741476

Cerebral oxygen saturation during the first 72h after birth in infants diagnosed prenatally with congenital heart disease.

Mirthe J Mebius1, Michelle E van der Laan2, Elise A Verhagen2, Marcus Tr Roofthooft3, Arend F Bos2, Elisabeth Mw Kooi2.   

Abstract

BACKGROUND: Evidence suggests that hypoxic-ischemic brain injury in infants with congenital heart disease already occurs during early life. The aim of our study was, therefore, to assess the course of regional cerebral oxygen saturation (rcSO2) and fractional tissue oxygen extraction (FTOE) during the first 72h after birth in infants with prenatally diagnosed duct-dependent congenital heart disease. In addition, we identified clinical parameters that were associated with rcSO2.
MATERIALS AND METHODS: We included 56 infants with duct-dependent congenital heart disease. We measured arterial oxygen saturation (SpO2) and rcSO2 during the first 72h after birth. Simultaneously, we calculated FTOE.
RESULTS: We observed median rcSO2 values of approximately 60%, a decreasing FTOE from 0.34 on day 1 to 0.28 on day 3 and stable preductal SpO2 values around 90%. Several clinical variables were associated with rcSO2. In a multiple linear regression model only type of CHD and preductal SpO2 were significant predictors of rcSO2 during the first three days after birth. Infants with a duct-dependent pulmonary circulation had up to 12% lower rcSO2 values than infants with a duct-dependent systemic circulation.
CONCLUSION: We demonstrated that, during the first three days after birth, cerebral oxygen saturation is low in infants with duct-dependent congenital heart disease. Furthermore, this study provides preoperative reference values of rcSO2 and FTOE in infants with duct-dependent CHD.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Congenital heart disease; Near-infrared spectroscopy; Neonatal intensive care unit; Newborn infants; Pulmonary circulation; Systemic circulation

Mesh:

Year:  2016        PMID: 27741476     DOI: 10.1016/j.earlhumdev.2016.10.001

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  10 in total

1.  Editorial based on: "Risk of dementia in adults with congenital heart disease: population-based cohort study".

Authors:  Mirthe J Mebius; Marcus T R Roofthooft; Arend F Bos
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Cerebral oxygen saturation and cerebrovascular instability in newborn infants with congenital heart disease compared to healthy controls.

Authors:  Nhu N Tran; Jodie K Votava-Smith; John C Wood; Ashok Panigrahy; Choo Phei Wee; Matthew Borzage; S Ram Kumar; Paula M Murray; Mary-Lynn Brecht; Lisa Paquette; Kenneth M Brady; Bradley S Peterson
Journal:  PLoS One       Date:  2021-05-10       Impact factor: 3.240

3.  Near-infrared spectroscopy as a predictor of clinical deterioration: a case report of two infants with duct-dependent congenital heart disease.

Authors:  Mirthe J Mebius; Gideon J du Marchie Sarvaas; Diana W Wolthuis; Beatrijs Bartelds; Martin C J Kneyber; Arend F Bos; Elisabeth M W Kooi
Journal:  BMC Pediatr       Date:  2017-03-16       Impact factor: 2.125

Review 4.  Interpretation of Cerebral Oxygenation Changes in the Preterm Infant.

Authors:  Aisling A Garvey; Elisabeth M W Kooi; Aisling Smith; Eugene M Dempsey
Journal:  Children (Basel)       Date:  2018-07-09

5.  De novo damaging variants associated with congenital heart diseases contribute to the connectome.

Authors:  Martina Brueckner; Mustafa K Khokha; Laura R Ment; Weizhen Ji; Dina Ferdman; Joshua Copel; Dustin Scheinost; Veronika Shabanova
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

6.  Hypoxic/ischemic hits predispose to necrotizing enterocolitis in (near) term infants with congenital heart disease: a case control study.

Authors:  Martin van der Heide; Mirthe J Mebius; Arend F Bos; Marcus T R Roofthooft; Rolf M F Berger; Jan B F Hulscher; Elisabeth M W Kooi
Journal:  BMC Pediatr       Date:  2020-12-07       Impact factor: 2.125

7.  CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL): study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trial.

Authors:  Raymond Stegeman; Maaike Nijman; Nicolaas J G Jansen; Manon J N L Benders; Johannes M P J Breur; Floris Groenendaal; Felix Haas; Jan B Derks; Joppe Nijman; Ingrid M van Beynum; Yannick J H J Taverne; Ad J J C Bogers; Willem A Helbing; Willem P de Boode; Arend F Bos; Rolf M F Berger; Ryan E Accord; Kit C B Roes; G Ardine de Wit
Journal:  Trials       Date:  2022-02-23       Impact factor: 2.279

Review 8.  Neuroplacentology in congenital heart disease: placental connections to neurodevelopmental outcomes.

Authors:  Rachel L Leon; Imran N Mir; Christina L Herrera; Kavita Sharma; Catherine Y Spong; Diane M Twickler; Lina F Chalak
Journal:  Pediatr Res       Date:  2021-04-16       Impact factor: 3.953

9.  Evolution of early cerebral NIRS in hypoxic ischaemic encephalopathy.

Authors:  Aisling A Garvey; John M O'Toole; Vicki Livingstone; Brian Walsh; Michael Moore; Andreea M Pavel; Lavinia Panaite; Mary Anne Ryan; Geraldine B Boylan; Deirdre M Murray; Eugene M Dempsey
Journal:  Acta Paediatr       Date:  2022-08-03       Impact factor: 4.056

10.  Onset of brain injury in infants with prenatally diagnosed congenital heart disease.

Authors:  Mirthe J Mebius; Catherina M Bilardo; Martin C J Kneyber; Marco Modestini; Tjark Ebels; Rolf M F Berger; Arend F Bos; Elisabeth M W Kooi
Journal:  PLoS One       Date:  2020-03-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.